Increasing effect by simultaneous use of levocabastine and pemirolast on experimental allergic conjunctivitis in rats

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 3, 2005, Pages 473-476

  Minami, Kazuhisa ^a   Hossen, Maria Alejandra ^a   Kamei, Chiaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Allergic conjunctivitis; Histamine release; Levocabastine; Pemirolast; Vascular permeability

Indexed keywords

ANTIGEN; ANTIHISTAMINIC AGENT; EYE DROPS; HISTAMINE; LEVOCABASTINE; PEMIROLAST;

ALLERGIC CONJUNCTIVITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; HISTAMINE RELEASE; MALE; NONHUMAN; RAT;

ANIMALS; CONJUNCTIVITIS, ALLERGIC; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HISTAMINE RELEASE; MALE; PIPERIDINES; PYRIDINES; PYRIMIDINONES; RATS; RATS, WISTAR;

EID: 21144449899     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.473     Document Type: Article

References (19)

1. Kamei C., Izushi K., Tasaka K., J Pharmacobio-Dyn., 14, 467-473 (1991).
2. Tasaka K., Kamei C., Akagi M., Mio M., Shirasaka T., Chokki M., Arzneim.-Forsch./Drug Res., 43, 1331-1337 (1993).
3. Odelram H., Bjorksten B., af Klercker T., Rimas M., Kjellman N. I., Blychert L. O., Allergy, 44, 432-436 (1989).
4. Frostad A. B., Olsen A. K., Clin. Exp. Allergy, 23, 406-409 (1993).
5. Abelson M. B., George M. A., Smith L. M., Ophthalmol., 102, 310-316 (1995).
6. Naclerio R. M., Clin. Exp. Allergy, 28 (Suppl. 6), 54-59 (1998).
7. Yanagihara Y., Kasai H., Kawashima T., Shida T., Jpn. J. Pharmacol., 48, 91-101 (1988).
8. Minami K., Kamei C., Int. Immunopharmacol., 4, 101-108 (2004).
9. Takada M., Yamada T., Nakahara H., Sugimoto Y., Izushi K., Kamei C., Biol. Pharm. Bull., 23, 566-569 (2000).
10. Kamei C., Izushi K., Nakamura S., Biol. Pharm. Bull., 18, 1518-1521 (1995).
11. Yanagihara Y., Kasai H., Shida T., Jpn. J. Pharmacol., 48, 103-112 (1988).
12. Togias A., J. Allergy Clin. Immunol., 112, S60-68 (2003).
13. Nakahara H., Izushi K., Sugimoto Y., Watanabe T., Kamei C., Eur. J. Pharmacol., 409, 313-317 (2000).
14. Schotte A., Leysen J. E., Laduron P. M., Naunyn. Schmiedebergs Arch. Pharmacol., 333, 400-405 (1986).
15. Yanni J. M., Miller S. T., Gamache D. A., Spellman J. M., Xu S., Sharif N. A., Ann. Allergy Asthma Immunol., 79, 541-545 (1997).
16. Lau H. Y. A., Pearce F. L., Agents Actions, 16, 176-178 (1985).
17. Goldschmidt P., Couturier C., Haeffner-Cavaillon N., Kazatchkine M., Herman D., Ocul. Immunol. Inflamm., 5, 11-17 (1997).
18. Fujimiya H., Nakashima S., Miyata H., Nozawa Y., Int. Arch. Allergy Appl. Immunol., 96, 62-67 (1991).
19. Minami K., Fujii Y., Kamei C., Int. Immunopharmacol., 4, 1531-1535 (2004).